AstraZeneca stays mum on Medicare drug pricing negotiations

Medicare has started negotiating drug prices for the first time, but neither the government nor the drug makers are revealing details. Last week, Medicare made its first offers to 10 drug manufacturers, leaving it up to them to discuss the proposals. AstraZeneca executives did not disclose any details about the price negotiation for their diabetes…

Read More

Management of chronic pain associated with temporomandibular disorders: a clinical practice guideline

Busse, Casassus, Carrasco-Labra, Durham, Mock, Zakrzewska, and others collaborated on a clinical practice guideline for managing chronic pain related to temporomandibular disorders. The guideline was published in BMJ in 2023. It provides evidence-based recommendations for the management of this type of pain, aiming to improve patient outcomes and reduce the burden of this condition. The…

Read More

How to stay healthy during cold, flu and COVID-19 season

As of 2022, January remains the worst month for respiratory illnesses, and hospital admissions have increased due to COVID-19 and other viruses. With vaccination rates low, it’s important to prioritize hand washing, good ventilation, and wearing a mask in crowded areas. Only 17% of Americans have received the updated COVID vaccine, which protects against the…

Read More

Health Bulletin 09/December/2023

NMC relief for overseas medical students in the Philippines allows students enrolled in BS courses before new regulations to continue their medical education. In Bihar, four doctors and a clerk at a medical institute have been accused of demanding sexual favors from paramedic students in exchange for better grades. Elsewhere, a doctor in Kerala has…

Read More

Itchy skin? Possible atopic dermatitis? Lavender essential oil might be just what you’re looking for

Researchers studied lavender essential oils in suppressing atopic dermatitis (AD) and found they effectively inhibit this skin condition and that linalyl acetate is the main contributor. The study used cell lines to establish the anti-AD benefits without human or animal testing. The tested components notably inhibit Artemin, a skin-stretching neurotrophic factor, and air pollution-induced AD,…

Read More

Covid-19: WHO adds JN.1 as new variant of interest

The World Health Organization has identified a new Covid-19 strain, JN.1, as a “variant of interest.” JN.1 is an offshoot of the omicron subvariant BA.2.86 and is considered by WHO to pose a “low” risk to global public health. The strain has been detected in multiple countries and is responsible for a significant portion of…

Read More